These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1587622)

  • 1. Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera.
    Lin JS; Yan LL; Ho Y; Rice PA
    Infect Immun; 1992 Jun; 60(6):2547-50. PubMed ID: 1587622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis.
    Peterson EM; Cheng X; Pal S; de la Maza LM
    Infect Immun; 1993 Feb; 61(2):498-503. PubMed ID: 8423079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.
    Peterson EM; Cheng X; Motin VL; de la Maza LM
    Infect Immun; 1997 Jul; 65(7):2693-9. PubMed ID: 9199438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors in cobra venoms affecting the complement system.
    Vogt W
    Toxicon; 1982; 20(1):299-303. PubMed ID: 7080043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antichlamydial activity of complement by chlamydia-secreted protease CPAF.
    Yang Z; Tang L; Zhou Z; Zhong G
    Microbes Infect; 2016 Nov; 18(11):669-674. PubMed ID: 27436813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C3 opsonization of Chlamydia trachomatis facilitates uptake in human monocytes.
    Lausen M; Christiansen G; Karred N; Winther R; Poulsen TBG; Palarasah Y; Birkelund S
    Microbes Infect; 2018; 20(6):328-336. PubMed ID: 29729435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK; Johnson RC; Dalmasso AP
    J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity.
    Noel GJ; Katz S; Edelson PJ
    J Infect Dis; 1988 Jan; 157(1):85-90. PubMed ID: 3257245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity.
    Peterson EM; Zhong GM; Carlson E; de la Maza LM
    Infect Immun; 1988 Apr; 56(4):885-91. PubMed ID: 3346076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of kinetics and target proteins for binding of human complement component C3 to the surface-exposed outer membrane of Chlamydia trachomatis serovar L2.
    Hall RT; Strugnell T; Wu X; Devine DV; Stiver HG
    Infect Immun; 1993 May; 61(5):1829-34. PubMed ID: 8478073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
    Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
    Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.
    Hodgetts SI; Grounds MD
    Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of recombinant cobra venom factor.
    Kock MA; Hew BE; Bammert H; Fritzinger DC; Vogel CW
    J Biol Chem; 2004 Jul; 279(29):30836-43. PubMed ID: 15131128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of serum IgG antibodies to Chlamydia trachomatis on the functional activity of complement components].
    Kozlov LV; Romanov SV; Andina SS; Bichucher AM; Kolesnikova EA; D'iakov VL
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):81-6. PubMed ID: 16830597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antilymphocytic antibodies and marrow transplantation. XIV. Antibody-induced suppression of graft-versus-host disease in C3-decomplemented mice differentiates two T-cell-depletion pathways.
    Thierfelder S; Mysliwietz J; Hoffmann-Fezer G; Kummer U
    Blood; 1991 May; 77(10):2285-91. PubMed ID: 2029584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of inactivation of Chlamydia trachomatis by normal human serum.
    Johnson AP; Osborn MF; Rowntree S; Thomas BJ; Taylor-Robinson D
    Br J Vener Dis; 1983 Dec; 59(6):369-72. PubMed ID: 6416608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability.
    Hew BE; Pangburn MK; Vogel CW; Fritzinger DC
    Toxicon; 2020 Sep; 184():68-77. PubMed ID: 32526239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The failure to show a necessary role for C3 in the in vitro antibody response.
    Waldmann H; Lachmann PJ
    Eur J Immunol; 1975 Mar; 5(3):185-93. PubMed ID: 1086224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative pathway of complement activation has a beneficial role against Chandipura virus infection.
    Gupta P; Tripathy AS
    Med Microbiol Immunol; 2020 Apr; 209(2):109-124. PubMed ID: 31781935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
    Hew BE; Fritzinger DC; Pangburn MK; Vogel CW
    Toxicon; 2019 Sep; 167():106-116. PubMed ID: 31207349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.